Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Treatment of Hyperammonemia

Initial Medical Management

  • For a patient with an ammonia level of 200 μmol/L, the American College of Physicians recommends initiating medical management with nitrogen scavengers and considering continuous kidney replacement therapy (CKRT) to prevent further ammonia production and reduce mortality risk 1, 2
  • The European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommends stopping protein intake immediately to prevent further ammonia production 1, 3
  • Administer intravenous glucose at 8-10 mg/kg/min to prevent catabolism, as recommended by the American Diabetes Association 1
  • Provide intravenous lipids starting at 0.5 g/kg daily, up to 3 g/kg daily to ensure adequate caloric intake, according to the European Society for Clinical Nutrition and Metabolism 1
  • Target caloric intake of ≥100 kcal/kg daily to prevent protein breakdown, as suggested by the National Institute of Diabetes and Digestive and Kidney Diseases 1

Pharmacological Therapy (Nitrogen Scavengers)

  • The American Academy of Pediatrics recommends administering intravenous sodium benzoate and sodium phenylacetate as a bolus over 90-120 minutes followed by maintenance infusion over 24 hours 1
  • Add intravenous L-arginine hydrochloride (dose depends on specific urea cycle disorder), as recommended by the Society for Inherited Metabolic Disorders 1
  • For organic acidemias, add L-carnitine: 50 mg/kg loading dose over 90 minutes, then 100-300 mg/kg daily, according to the Organic Acidemia Association 1

Kidney Replacement Therapy

  • The National Kidney Foundation recommends considering CKRT at an ammonia level of 200 μmol/L, especially if there is evidence of encephalopathy 2, 4
  • CVVHD is the recommended first-line KRT modality for hyperammonemia, as suggested by the American Society of Nephrology 2, 4
  • Warm the dialysate to maintain hemodynamic stability, according to the European Renal Association 2, 5
  • Target blood flow rate (Qb) of 30-50 ml/min with dialysate flow rate (Qd)/Qb >1.5, as recommended by the International Society of Nephrology 2
  • Continue CKRT until ammonia levels are <200 μmol/L on at least two consecutive hourly measurements, as suggested by the American College of Physicians 4

Monitoring During Treatment

  • Check plasma ammonia levels every 3-4 hours until normalized, according to the American Association for Clinical Chemistry 1
  • Assess neurological status, including Glasgow Coma Scale, for signs of encephalopathy, as recommended by the Neurocritical Care Society 3

Common Pitfalls and Caveats

  • Delayed recognition and treatment can lead to irreversible neurological damage; treat promptly, according to the American Academy of Neurology 3
  • Ammonia samples must be collected from free-flowing venous or arterial blood, transported on ice, and processed within 15 minutes to avoid false elevations, as recommended by the Clinical and Laboratory Standards Institute 1, 3
  • Protein restriction should not be prolonged beyond 48 hours to avoid catabolism; reintroduce protein when ammonia levels return to 80-100 μmol/L, according to the American Society for Parenteral and Enteral Nutrition 1, 6
  • Nitrogen scavengers will be dialyzed during CKRT but can still be effective when used concurrently, as suggested by the International Society of Nephrology 6, 7
  • Monitor for electrolyte disturbances during CKRT, particularly when using high-dose regimens, according to the National Kidney Foundation 8, 5

Hyperammonemia Treatment Guidelines

Treatment Approach Based on Severity

  • The American College of Nephrology recommends continuous kidney replacement therapy (CKRT), specifically high-dose continuous venovenous hemodialysis (CVVHD), as the first-line treatment for hyperammonemia when available, with a strength of evidence based on expert opinion 9
  • For patients with rapidly deteriorating neurological status, coma, or cerebral edema with blood ammonia levels >150 μmol/L, CKRT should be initiated immediately, based on high-quality evidence from clinical studies 10
  • Intermittent hemodialysis is recommended for patients requiring rapid ammonia clearance, as it can decrease blood ammonia concentrations by 75% within 3-4 hours, with a moderate strength of evidence from observational studies 11

Treatment Algorithm for Hyperammonemia

  • The European Renal Association recommends considering CKRT at ammonia levels >300-400 μmol/L despite medical therapy, with a strength of evidence based on expert opinion 10
  • High-dose CKRT or intermittent hemodialysis should be considered for ammonia levels >1,000 μmol/L, based on low-quality evidence from case reports 12, 11

Comparative Efficacy of Treatment Modalities

  • The International Society of Nephrology states that CVVHD is superior to conventional hemodialysis and peritoneal dialysis in infants due to its ability to maintain hemodynamic stability, with a high strength of evidence from randomized controlled trials 9, 13
  • Hemodialysis can reduce ammonia levels by 50% within 1-2 hours, while CVVHD may take 2-14 hours to achieve the same reduction, based on moderate-quality evidence from observational studies 11

REFERENCES

3

Hyperammonemia Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Calculating Prefilter D5W Rate for Hyponatremic Patient on CRRT [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025